Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Toshihiro Nukiwa, Toumei Tsukamoto et al.|Journal of Clinical Oncology|2008Cited by 235